Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
  1. 4 Grant or award Director acquired 4,698 shares (grant or award)
  2. 4 Shares withheld for taxes President and CEO gave up 38,873 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 16,906 shares (to pay taxes)
  4. 4 Exercise or conversion Director acquired 3,800 shares (option exercise)
  5. 4 Open-market sale Director sold 4,150 shares at $9.02 ($37,435)
  6. 4 Open-market sale Director sold 10,000 shares at an average $8.22 ($82,208)
  7. 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 12,713 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Shares withheld for taxes EVP, CCO and CBO gave up 317 shares (to pay taxes)
  11. 4 Exercise or conversion EVP, CFO and Treasurer acquired 2,367 shares (option exercise)
  12. 4 Open-market sale Director sold 7,500 shares at $14.09 ($105,675)
  13. 4 Open-market sale Director sold 7,500 shares at an average $13.72 ($102,881)
  14. 4 Open-market sale President, R&D sold 13,904 shares at an average $14.47 ($201,164)
  15. 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 6,670 shares (option exercise)

Page 4 of 38 · 752 filings